๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

In vitro dissolution and in vivo bioavailability of commercial levothyroxine sodium tablets in the hypothyroid dog model

โœ Scribed by Ray W. Wood; Leo Martis; Amy W. Gillum; Theodore J. Roseman; Lawrence Lin; Peter Bernardo

Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
514 KB
Volume
79
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

In vitro and in vivo assessment of the b
In vitro and in vivo assessment of the bioavailability of potassium from a potassium tartrate tablet
โœ Susan J. Whiting; Dennis K. J. Gorecki; Dennis Jones ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 338 KB ๐Ÿ‘ 2 views

The bioavailability of potassium from orally administered potassium tartrate was evaluated in 20 normal subjects under metabolic balance conditions. Subjects were given 34 mmol potassium (5 tablets of Cal-K@) as a divided dose on each of 2 consecutive days. Urinary excretion of potassium, as determi

A biopharmaceutic approach in designing
A biopharmaceutic approach in designing a controlled release tablet of sodium monofluorophosphate: 1. in vitro and in vivo studies in beagle dogs
โœ Chandra S. Vattikonda; Wolfgang A. Ritschel ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 617 KB

The purpose of this study was to develop a controlled release tablet (CRT) of sodium monofluorophosphate (NaMFP) based on biopharmaceutic and pharmacokinetic principles. NaMFP was introduced in the early eighties to treat osteoporosis. The required dose size (200 mg of NaMFP) and time of drug delive